Dahap, Jerzelie .

HRN: 22-25-70  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2022
CEFUROXIME 500MG (TAB)
11/29/2022
12/05/2022
PO
500mg
BID
UTI
Waiting Final Action 
11/29/2022
CEFUROXIME 1.5GM (VIAL)
11/29/2022
11/30/2022
IVT
1.5gm X 6 Doses
Q8
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: